218 related articles for article (PubMed ID: 32431449)
1. Systematic Review of Postfertilization Effects and Potential for Embryo Formation and Loss during the Use of Intrauterine Devices.
Buskmiller C; Harrison D; Ruppersberger LA; Yeung PP
Linacre Q; 2020 Feb; 87(1):60-77. PubMed ID: 32431449
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
[TBL] [Abstract][Full Text] [Related]
3. Urinary human chorionic gonadotropin among intrauterine device users: detection with a highly specific and sensitive assay.
Wilcox AJ; Weinberg CR; Armstrong EG; Canfield RE
Fertil Steril; 1987 Feb; 47(2):265-9. PubMed ID: 3817172
[TBL] [Abstract][Full Text] [Related]
4. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
French R; Van Vliet H; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Helmerhorst F; Guillebaud J
Cochrane Database Syst Rev; 2004; 2004(3):CD001776. PubMed ID: 15266453
[TBL] [Abstract][Full Text] [Related]
5. Absence of chorionic gonadotropin in sera of women who use intrauterine devices.
Segal SJ; Alvarez-Sanchez F; Adejuwon CA; Brache de Mejia V; Leon P; Faundes A
Fertil Steril; 1985 Aug; 44(2):214-8. PubMed ID: 4018277
[TBL] [Abstract][Full Text] [Related]
6. The mode of action of IUDs.
Ortiz ME; Croxatto HB
Contraception; 1987 Jul; 36(1):37-53. PubMed ID: 3311625
[TBL] [Abstract][Full Text] [Related]
7. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
French R; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Guillebaud J
Cochrane Database Syst Rev; 2001; (2):CD001776. PubMed ID: 11406007
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of action of intrauterine devices.
Ortiz ME; Croxatto HB; Bardin CW
Obstet Gynecol Surv; 1996 Dec; 51(12 Suppl):S42-51. PubMed ID: 8972502
[TBL] [Abstract][Full Text] [Related]
9. The safety of intrauterine devices among young women: a systematic review.
Jatlaoui TC; Riley HEM; Curtis KM
Contraception; 2017 Jan; 95(1):17-39. PubMed ID: 27771475
[TBL] [Abstract][Full Text] [Related]
10. Early chorionic activity in women bearing inert IUD, copper IUD and levonorgestrel-releasing IUD.
Videla-Rivero L; Etchepareborda JJ; Kesseru E
Contraception; 1987 Aug; 36(2):217-26. PubMed ID: 3123135
[TBL] [Abstract][Full Text] [Related]
11. Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction.
Craciunas L; Tsampras N; Coomarasamy A; Raine-Fenning N
Cochrane Database Syst Rev; 2016 May; (5):CD011537. PubMed ID: 27195724
[TBL] [Abstract][Full Text] [Related]
12. Human chorionic gonadotrophin (hCG) in IUD users.
Dhont M; Thiery M; Vanlancker M
IRCS J Med Sci; 1984 Sep; 12(9):862. PubMed ID: 12340100
[TBL] [Abstract][Full Text] [Related]
13. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
Heinemann K; Reed S; Moehner S; Minh TD
Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
[TBL] [Abstract][Full Text] [Related]
14. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures.
Huang SC; Chen HC; Chen RJ; Hsieh CY; Wei PY; Ouyang PC
J Clin Endocrinol Metab; 1984 Apr; 58(4):646-53. PubMed ID: 6699130
[TBL] [Abstract][Full Text] [Related]
15. Hormonal intrauterine devices.
Rybo G; Andersson K; Odlind V
Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
[TBL] [Abstract][Full Text] [Related]
16. Chlamydial serologic characteristics among intrauterine contraceptive device users: does copper inhibit chlamydial infection in the female genital tract?
Mehanna MT; Rizk MA; Ramadan M; Schachter J
Am J Obstet Gynecol; 1994 Sep; 171(3):691-3. PubMed ID: 8092216
[TBL] [Abstract][Full Text] [Related]
17. Morphological changes in tubal mucosa associated with the use of intrauterine contraceptive devices.
Wollen AL; Flood PR; Sandvei R; Steier JA
Br J Obstet Gynaecol; 1984 Nov; 91(11):1123-8. PubMed ID: 6498128
[TBL] [Abstract][Full Text] [Related]
18. The pathology of intra-uterine contraceptive devices.
Buckley CH
Curr Top Pathol; 1994; 86():307-30. PubMed ID: 8162713
[TBL] [Abstract][Full Text] [Related]
19. Endometrial reaction to intrauterine device in pregnancy.
Ezra Y; Birkenfeld A; Levij IS
Gynecol Obstet Invest; 1989; 28(1):5-7. PubMed ID: 2777135
[TBL] [Abstract][Full Text] [Related]
20. In vitro fertilization and multiple pregnancies: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(18):1-63. PubMed ID: 23074488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
